NYSE: PRLBProto Labs Inc Stock
$35.41+0.02 (+0.06%)
Updated Apr 29, 2025
PRLB Price
$35.41
Fair Value Price
N/A
Market Cap
$858.10M
52 Week Low
$25.76
52 Week High
$46.73
P/E
53.65x
P/B
1.28x
P/S
1.96x
PEG
2.91x
Dividend Yield
N/A
Revenue
$500.89M
Earnings
$16.59M
Gross Margin
44.6%
Operating Margin
4.93%
Profit Margin
3.3%
Debt to Equity
0.11
Operating Cash Flow
$78M
Beta
1.3
Next Earnings
May 1, 2025
Ex-Dividend
N/A
Next Dividend
N/A
PRLB Overview
Proto Labs, Inc. digitally manufactures custom prototypes and on-demand production parts. Specific offerings include injection molding, computer numerical control machining, and 3D printing. It offers its solutions to product developers and engineers who use 3D CAD software. Proto Labs was incorporated in 1985 and is headquartered in Houston, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PRLB's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Metal Fabrication
Industry Rating
A
PRLB
Ranked#6 of 14
Ranked#6 of 14
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $50.45 | A | |
| $33.15 | B | |
| $42.88 | B |
Be the first to know about important PRLB news, forecast changes, insider trades & much more!
PRLB News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PRLB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PRLB ($35.41) is trading above its intrinsic value of $8.03, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PRLB is poor value based on its earnings relative to its share price (53.65x), compared to the US market average (29.19x)
P/E vs Market Valuation
PRLB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more PRLB due diligence checks available for Premium users.
Valuation
PRLB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
53.65x
Industry
20.72x
Market
29.19x
PRLB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PRLB is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
PRLB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.28x
Industry
3.41x
PRLB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PRLB price to earnings growth (PEG)
For valuing profitable companies with growth potential
PRLB is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
PRLB's financial health
Profit margin
Revenue
$121.8M
Net Income
-$404.0k
Profit Margin
-0.3%
PRLB's Earnings (EBIT) of $24.67M... subscribe to Premium to read more.
Interest Coverage Financials
PRLB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$743.5M
Liabilities
$73.4M
Debt to equity
0.11
PRLB's short-term assets ($194.85M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PRLB's short-term assets ($194.85M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PRLB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PRLB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$17.3M
Investing
-$2.9M
Financing
-$12.5M
PRLB's operating cash flow ($77.83M)... subscribe to Premium to read more.
Debt Coverage Financials
PRLB vs Metal Fabrication Stocks
Proto Labs Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.